Hepatitis is an inflammation of the liver that is caused by a variety of infectious viruses and noninfectious agents leading to a range of health problems, some of which can be fatal. An estimated 354 million people worldwide live with hepatitis B or C, and most of them are hard to reach testing and treatment. There are five main strains of the hepatitis virus, referred to as types A, B, C, D and E. While they all cause liver disease, they differ in important ways including transmission modes, severity of the illness, geographical distribution and prevention methods.    Hepatitis B and C Infection  Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are major causes of acute and chronic liver disease (e.g. liver cirrhosis and liver cancer) globally, and cause an estimated 1.4 million deaths annually.     Testing and diagnosis of hepatitis B and C infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of HBV or HCV infection enables patients to receive the necessary care and treatment to prevent or delay progression of liver disease. Testing also provides an opportunity to link people to interventions to reduce transmission, through counselling on risk behaviors and provision of prevention commodities (such as sterile needles and syringes) and hepatitis B vaccination.     Importance of Testing and Diagnosis of Hepatitis B and C  Most people infected with HBV and/or HCV remain unaware of their infection and therefore frequently present with advanced disease and may transmit infection to others despite the advances and opportunities for treatment.  Getein Reliable Tool for Diagnosis of Hepatitis and Chronic Liver Disease  As a trusted in vitro diagnostic national enterprise in China, Getein has been at the forefront of developing comprehensive tests for HBV & HCV infection and liver disease caused by hepatitis virus infection, which enables healthcare professionals to rapidly and effectively diagnose and control allergies, make informed treatment decisions and improve patient outcomes.     Getein will continuously pay close attention to global health issues and needs in real time, to help combat the pandemic, reduce the burden on healthcare systems and optimize patient management. References: Health topics: Hepatitis. WHO World Hepatitis Day. WHO

Getein at AACC 2022     We sincerely invite you to visit us and to experience our latest innovations!    Date: July, 26-28th, 2022   Location: Chicago, Illinois, McCormick Place Convention Center      Booth No. #1752   Check the following to have a glance at our products that will show in our booth.               Lastly, please check the video here to know more about us at AACC 2022. We are waiting for you!    

WHO has sounded the alarm about the rise in Monkeypox cases in Europe and elsewhere. Since the first case of monkeypox was confirmed in London on May 7 (the patient was a traveler from Nigeria, where monkeypox has recently been endemic), more and more countries have reported cases in the following days and weeks, which is "atypical" for monkeypox. Monkeypox is an infection caused by the monkeypox virus, which used to be predominantly endemic in West and Central Africa. Confirmed and suspected cases of monkeypox are now present in several Western countries, including the United Kingdom, Portugal, Spain, Italy, Sweden, the United States, Canada, and Australia...   Map: Where has monkeypox been detected so far? Source: Infographic News - WiredPRNews.com   The World Health Organization (WHO) said that as of May 26, 269 confirmed cases and 74 suspected cases of monkeypox had been reported in 21 countries worldwide. Meanwhile, WHO has expanded surveillance in non-endemic countries and will guide countries on monkeypox prevention in the coming days.   Source: BNO News   Diagnosis of Monkeypox Virus——   Clinical identification of monkeypox is the first step in the diagnosis. Confirmation of the diagnosis of monkeypox in the current domestic and international market requires a series of laboratory tests; among these tests are： 1) Polymerase chain reaction (PCR) analysis. 2) cell culture isolation of the virus. 3) Enzyme-linked immunosorbent assay (ELISA). 4) Antigen detection test.   It is essential to note that antigen and antibody tests do not provide monkeypox-specific confirmation due to the cross-reactive nature of monkeypox virus serology. Therefore, serological and antigenic assays are not recommended for diagnostic or case investigation in resource-limited areas. PCR and cell culture isolation of virus indicate virus presence in the sample to be tested. Given their accuracy and sensitivity, the samples for PCR monkeypox are vesicles, pustular fluid, crusts, and blood specimens, with the best diagnostic samples coming from the tops or fluids of vesicles and pustules of skin lesions and dried crusts.       Getein Monkeypox Virus Real-time PCR Test Solution ——   Step 1：Disposable Virus Sampling Tube The first step of the Getein monkeypox virus solution is sample extraction, starting with the Disposable Virus Sampling Tube. This tube collects, transports, and stores human nasopharyngeal virus and rash fluid samples. The disposable virus sampling tube contains guanidine salt, which can inactivate the virus and keep the virus nucleic acid stable. The sample preservation solution has a stable transportation and storage environment.     Step 2：Nucleic Acid Extraction Kit The second step of this solution is to extract and purify viral nucleic acids (DNA and RNA) in samples. This kit consists of unique separation function magnetic beads and a unique buffer system. The m...